Data as of Aug 29
| +0.28 / +1.53%|
The 12 analysts offering 12-month price forecasts for Auxilium Pharmaceuticals Inc have a median target of 29.00, with a high estimate of 34.00 and a low estimate of 14.00. The median estimate represents a +55.91% increase from the last price of 18.60.
The current consensus among 12 polled investment analysts is to Buy stock in Auxilium Pharmaceuticals Inc. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.